Over‐Representation of TTN Truncating Variants in a Finnish Cohort of Patients With Axial Myopathy
European Journal of Neurology · 2026
DOI: 10.1111/ene.70537 ↗At a glance
Journal article in European Journal of Neurology, 2026. Written by Maria Francesca Di Feo and 5 co-authors. Institution: Folkhälsan Research Center, Helsinki, Finland. Major MEDLINE topics: Connectin, Muscular Diseases, Spinal Curvatures. 17 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Commission, Research Council of Finland, Samfundet Folkhälsan.
Abstract (original language)
Background
Axial myopathies present with late onset selective paravertebral weakness causing bent spine/camptocormia or dropped head, and the genetic basis remains currently only partially understood. Truncating variants in TTN (TTNtv) are found in about 1% of the general population and, when biallelic, cause recessive titinopathies. Also, TTNtv located in cardiac exons are known to confer an increased risk of cardiomyopathy, with incomplete penetrance.
Methods
We retrospectively analyzed 55 Finnish adults with late‐onset axial myopathy evaluated at the Tampere Neuromuscular Center (2015–2025). Clinical, imaging, and histopathological data were collected, and genetic testing was performed using the MYOcap targeted next‐generation sequencing panel.
Results
Heterozygous TTNtv were identified in 9 of 55 patients (16%), representing a significant enrichment compared with the general population (odds ratio = 14.1; p ≈5 × 10 −8 ). The variants were ultra‐rare, distributed across different exons expressed in skeletal muscle, and five were absent from gnomAD. Mean age at onset was 60 ± 11 years; six patients were female, and five reported a positive family history. Camptocormia was the main presentation, with muscle MRI showing a consistent fatty‐fibrous replacement of paravertebral muscles in all cases. Muscle biopsies revealed either myopathic or myofibrillar changes without a uniform pattern.
Conclusions
Heterozygous TTNtv are significantly enriched in patients with late‐onset axial myopathy, suggesting a potential contribution to this phenotype. These findings broaden the clinical spectrum of titin‐related diseases and support inclusion of TTN in genetic testing for idiopathic axial myopathies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Folkhälsan Research Center, Helsinki, Finland.
- University of Helsinki, Helsinki, Finland.
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (DINOGMI), University of Genoa, Genova, Italy.
- Department of Neuroscience DNS, University of Padova, Padova, Italy.
- Neuromuscular Research Center, Tampere University and University Hospital, Tampere, Finland.
- Vasa Central Hospital, Ostrobothnia, Finland.
ORCID profiles: Maria Francesca Di Feo, Bjarne Udd, Manu Jokela
Funding
- European Commission
- Research Council of Finland
- Samfundet Folkhälsan
- Sigrid Juséliuksen Säätiö
- Suomen Kulttuurirahasto
- Tays
Cite
APA
Di Feo, M. F., Capece, G., Savarese, M., Udd, B., Jokela, M., & Palmio, J. (2026). Over‐Representation of TTN Truncating Variants in a Finnish Cohort of Patients With Axial Myopathy. European Journal of Neurology. https://doi.org/10.1111/ene.70537
Vancouver
Di Feo MF, Capece G, Savarese M, Udd B, Jokela M, Palmio J. Over‐Representation of TTN Truncating Variants in a Finnish Cohort of Patients With Axial Myopathy. European Journal of Neurology. 2026. doi:10.1111/ene.70537
BibTeX
@article{DiFeo2026,
author = {Di Feo, Maria Francesca and Capece, Giuliana and Savarese, Marco and Udd, Bjarne and Jokela, Manu and Palmio, Johanna},
title = {Over‐Representation of TTN Truncating Variants in a Finnish Cohort of Patients With Axial Myopathy},
journal = {European Journal of Neurology},
year = {2026},
doi = {10.1111/ene.70537}
}
EUVIMED